Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
30.80    -0.60 (-1.91%)
Bid:
30.00
Ask:
30.80
Spread: 0.80 (2.667%)
Market Cap: £83.88m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

Biofuels Update

18 Mar 2011 07:06

RNS Number : 1999D
Pursuit Dynamics PLC
18 March 2011
 



18 March 2011

 

Pursuit Dynamics PLC (AIM: PDX)

("PDX" or the "Company')

 

Biofuels update

 

PDX is pleased to announce today that it has agreed to formal terms with Pacific Ethanol Columbia LLC for the commercial operation of the Ethanol Reactor System ("ERS") installation at its Columbia Plant near Boardman, Oregon (USA). The agreement, which is in line with previous guidance, ensures that PDX would share in the full range of benefits that accrue to Pacific Ethanol Columbia through operating the ERS, which we believe will include an enhanced yield, reduced operating cost, reduced enzyme costs and improved cycle times.

 

Commenting on the announcement, Neil Koehler, CEO of Pacific Ethanol, Inc. (NASDAQ CM: PEIX), which manages the plant, stated:

 

"The agreement with PDX enables the continued operation of the ERS and verification of the benefits it delivers at the Pacific Ethanol Columbia plant in Boardman, Oregon. We are pleased to advance our relationship with PDX as it demonstrates our continued focus on introducing new technology that will enable us to enhance the yields on corn ethanol and optimizing the overall performance of our ethanol production plants."

 

Commenting on the announcement, Roel Pieper, CEO of PDX said:

 

"Today's announcement is the culmination of a tremendous amount of hard work on behalf of the team who have worked diligently and tirelessly to demonstrate the ERS's commercial potential. We now look forward to growing the business further and continuing to drive commercial returns."

 

- Ends -

 

For Further Information, please contact:

 

PDX

Roel Pieper, CEO

Tel: +44 (0)1480 422050

Richard Webster, CFO

Financial Dynamics

Ben Foster

Marc Cohen

Tel: +44 (0) 20 7831 3113

Tel: +44 (0) 7802 877 241

 

 

Cenkos Securities

Ian Soanes

Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities

Rory Scott

Tel: +44 (0) 20 7878 3360

 

 

Notes to Editors

 

About PDX

 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

 

- The PDX business model is currently organised into six Lines of Business - Biofuels; Brewing, Food and Beverages; Public Health and Decontamination; Industrial Licensing; Water and New Ventures.

 

- PDX is headquartered in Huntingdon (UK) with an office in London (UK), Schaffhausen (Switzerland) and Connecticut (USA).

 

- Further information is available at the Company's website: www.pdx.biz 

 

- Publication quality photographs are available from FD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDVLBFFXFBBBE
Date   Source Headline
30th Jul 202512:15 pmRNSTotal Voting Rights and Share Capital
30th Jul 202512:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20253:37 pmRNSTotal Voting Rights and Share Capital
25th Jun 202511:45 amRNSDirector/PDMR Shareholding & Total Voting Rights
23rd Jun 202512:47 pmRNSHolding(s) in Company
4th Jun 202512:40 pmRNSResult of AGM
2nd Jun 20252:01 pmRNSTotal Voting Rights and Share Capital
15th May 20253:00 pmRNSAdoption and grant of options
1st May 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:02 amRNSShare Buyback Programme
31st Mar 20257:00 amRNSAnnual Results 2024
28th Feb 202512:05 pmRNSTotal Voting Rights and Share Capital
4th Feb 20257:00 amRNSFY24 Pre-Close Trading Update
29th Jan 20253:45 pmRNSBlock Listing Six Monthly Return
22nd Jan 20253:20 pmRNSHolding(s) in Company
11th Sep 20247:00 amRNSInterim Results
7th Aug 20243:00 pmRNSAdoption and grant of options
2nd Aug 20245:00 pmRNSShare Capital Reduction
30th Jul 20247:00 amRNSPre-Close Trading Update
29th Jul 20248:00 amRNSBlock Listing Six Monthly Return
27th Jun 20242:20 pmRNSTotal Voting Rights and Share Capital
14th Jun 20249:57 amRNSResult of AGM
2nd Apr 20247:01 amRNSInvestor Presentation
2nd Apr 20247:00 amRNSAnnual Results 2023
27th Mar 20244:05 pmRNSTotal Voting Rights and Share Capital
5th Feb 20247:00 amRNSPre-Close Trading Update
30th Jan 20244:00 pmRNSTotal Voting Rights and Share Capital
30th Jan 20244:00 pmRNSBlock Listing Six Monthly Return
30th Nov 20237:00 amRNSTotal Voting Rights and Share Capital
28th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.